Evidence map›Paper›PMID 29661157›Full record

ArticleBMC infectious diseases2018

Sub-inhibitory concentrations of oxacillin modify the expression of agr locus in Staphylococcus aureus clinical strains belonging to different clonal complexes.

Esther Viedma, Dafne Pérez-Montarelo, Jennifer Villa, Irene Muñoz-Gallego, Nieves Larrosa, Nuria Fernández-Hidalgo, Joan Gavaldà, Benito Almirante, Fernando Chaves

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Analysis of the Presence of the Virulence and Regulation Genes fromInternational journal of environmental research and public health · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Sodium Butyrate ReducesFrontiers in microbiology · 2020
    Article
  10. Hypericin enhancesActa pharmaceutica Sinica. B · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Esther ViedmaDepartment of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain. ester.viedma@salud.madrid.org.
Dafne Pérez-MontareloDepartment of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Jennifer VillaDepartment of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Irene Muñoz-GallegoDepartment of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Nieves LarrosaDepartment of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Nuria Fernández-HidalgoDepartment of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Joan GavaldàDepartment of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Benito AlmiranteDepartment of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Fernando ChavesDepartment of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Hospital Universitario 12 De Octubre · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe ability of Staphylococcus aureus to invade tissues and cause an infectious disease is the result of a multi-factorial process supported by the huge number of virulence factors inherent to this microorganism tightly regulated by the accessory gene regulator (agr). During antimicrobial therapy bacteria may be exposed to sub-inhibitory concentrations (subMICs) of antibiotics that may trigger transcriptional changes that may have an impact on the pathogenesis of infection. The objective of this study was to investigate the effect of oxacillin sub-MICs on agr system expression as the key component in the regulation of virulence in methicillin-susceptible (MSSA) and -resistant S. aureus (MRSA) strains. Furthermore, we studied the genetic basis of the agr locus and their potential association with the expression levels.

methodsWe have examined the expression of RNAIII and agrA mRNA as biomarkers for agr expression in the presence and absence of oxacillin subMICs in 10 MSSA and 4 MRSA clinical strains belonging to 5 clonal complexes (CC45-agrI, CC8-agrI, CC5-agrII, CC15-agrII and CC30-agrIII) causing endovascular complications. The DNA sequences of agr locus were obtained by whole genome sequencing.

resultsOur results revealed that exposure to subMICs of oxacillin had an impact on agr locus expression modifying the relative levels of expression with increases in 11 strains and with decreases in 3 strains. Thereby, the exposure to subMICs of oxacillin resulted in higher levels of expression of agr in CC15 and CC45 and lower levels in CC30. We also observed the presence of mutations in agrC and agrA in 13/14 strains with similar mutation profiles among strains within individual CCs except for strains of CC5. Although, agr expression levels differed among strains within CCs, the presence of these mutations was associated with differences in agr expression levels in most cases.

conclusionsChanges in agr expression induced by exposure to oxacillin subMICs should be considered because they could lead to changes in the virulence modulation and have an adverse effect on the course of infection, especially in certain clonal complexes.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsGene Expression Regulation, BacterialHumansMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMutationOperonOxacillinProtein KinasesStaphylococcal InfectionsStaphylococcus aureusTrans-ActivatorsVirulenceVirulence FactorsAgrC protein, StaphylococcusAgr protein, Staphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsOxacillinProtein KinasesTrans-ActivatorsVirulence Factorsagr locus expressionagr mutationsClonal complexOxacillinStaphylococcus aureusSub-inhibitory concentrations

Identifiers

PMID29661157
PMCPMC5902860
OpenAlexW2804864639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.